ArticleCureus2026
A Clinical and Economic Framework for Identifying Potentially Avoidable Infection-Related Costs Following Minimally Invasive Aesthetic Procedures.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Minimally invasive aesthetic procedures have steadily increased because of their accessibility, rapid recovery, and perceived low risk. However, disruption of the skin barrier, implantation of materials, manipulation of injectable products, and variability in biosafety practices may favor uncommon but clinically relevant infectious complications. This technical report proposes a clinical-economic framework to identify the clinical burden, health care resource use, and potentially avoidable costs associated with infections following procedures such as dermal fillers, botulinum toxin, mesotherapy, thread lifts, and other facial or body aesthetic interventions. The framework integrates clinical pathways in which infections may present as cellulitis, abscesses, persistent inflammatory nodules, granulomas, biofilm-associated complications, or delayed infections caused by rapidly growing nontuberculous mycobacteria, particularly
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.